Business Wire

DAWEX

11.5.2022 08:47:13 CEST | Business Wire | Press release

Share
MGTS Creates the First Data Marketplace Specialized in the Automotive and Individual Mobility Sector Relying on Dawex Data Exchange Technology

Dawex , the leading technology company for data exchange, data marketplace and data hub, unveils the MGTS Data Marketplace, the first non-personal data marketplace for the automotive sector (distribution, sales, use, wear and tear, maintenance and equipment), and more globally for individual mobility. The MGTS Data Marketplace aims at bringing together all stakeholders and observers of today's and tomorrow's individual mobility to enable its users to understand, anticipate and innovate in this rapidly changing sector.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220505006017/en/

Present in 18 countries with 2,000 customer contact points under the Midas, Norauto and ATU multi-brand car maintenance banners, Mobivia is the leader in its sector with over 50 million customers per year and 50 years of existence.

"Dawex provided us with the technology solution to monetize and generate value from our data or those of our partners, by creating a Data Exchange Platform that is powerful, efficient, secure and easy to use," explains Ludovic Codeluppi, International Product Leader at MGTS.

The MGTS Data Marketplace leverages Dawex Data Exchange technology to facilitate the collection, centralization, distribution, exchange and monetization of non-personal data in this sector. The different market players keep control over their data, decide with whom to share it and for what purposes, in an environment that guarantees security and traceability. Thanks to Dawex business and regulatory expertise, the MGTS Data Marketplace meets the requirements of European and international regulations, and is perfectly in line with the future Data Act .

"In less than a year, MGTS has built strong relationships with organizations outside of our immediate ecosystem thanks to Dawex introductions," continues Ludovic Codeluppi. "The circulation and commercialization of data between these stakeholders will play a key role in the development of new business models.”

Dawex technology enables MGTS to orchestrate and animate a vast data ecosystem from the automotive and mobility sector. It provides its stakeholders with the means to better understand and improve their user experience, increase productivity and efficiency, and boost innovation. The MGTS deployment is another illustration of Dawex technology leadership, demonstrating the footprint of its solid reference architecture.

"Data exchange has become a fundamental component of business competitiveness and economic sovereignty," comments Fabrice Tocco, Dawex co-CEO. "Organizing the circulation and monetization of its data within its ecosystem is an imperative for all players in the retail sector.”

Sign up to the MGTS Data Marketplace

About Dawex

In today’s economy where data has become a product of unlimited potential, with its own value, and a source of new revenue streams, Dawex technology allows organizations to create new ecosystems around data exchange platforms that meet regulatory requirements and address traceability and security challenges. Dawex is the leading technology company for data exchange , data marketplace and data hub to orchestrate the sourcing, the distribution and the exchange of data. Awarded Technology Pioneer by the World Economic Forum in 2020, Dawex is an active member of Gaia-X . Created in 2015, Dawex is headquartered in France, expanding business operations to Europe, Asia, North America and the Middle East.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Strongest Half-Year in Curatis’s History — Revenue up 51% and Significant Progress on Corticorelin (C-PTBE-01)21.9.2026 07:03:00 CEST | Press release

Curatis Holding AG (SIX:CURN, “Curatis”) reports net sales from goods and services of CHF 7.9m for the first half of 2026, up 51% (H1 2025: CHF 5.2m), with the loss for the period narrowing to CHF -0.4m (H1 2025: CHF -1.2m) and cash and cash equivalents rising to CHF 3.6m (31 December 2025: CHF 1.9m). Curatis also advanced its corticorelin (C-PTBE-01) program on multiple levels, including an exclusive Japan licence with Neupharma and continued manufacturing progress. Business development and finances Net sales from goods increased by 46% to CHF 7.4m (H1 2025: CHF 5.0m) and net sales from services rose to CHF 0.6m (H1 2025: CHF 0.2m). Growth was driven both by products marketed for some time and by products added to the distribution portfolio in 2025 and 2026. The gross contribution from goods and services rose by 32% to CHF 1.8m (H1 2025: CHF 1.3m); the combined cost base grew by only 9% against net sales growth of 51%, as personnel expenses rose 5% to CHF 1.3m (H1 2025: CHF 1.2m) and

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies21.9.2026 07:00:00 CEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today begins trading as a constituent of the Swiss Market Index (SMI), Switzerland's leading blue chip equity benchmark comprising 20 of the country's largest and most liquid listed companies. Less than three years after its IPO on the SIX Swiss Exchange in March 2024, Galderma has established itself as one of Switzerland's leading listed companies. Its inclusion in the SMI reflects the company's strong growth, disciplined execution and increasing relevance in Swiss and international capital markets as it advances its ambition to become the world's leading dermatology powerhouse. Since its IPO, Galderma has continued to execute its growth-focused integrated dermatology strategy, delivering strong performance across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Net sales increased from 4.410 billion USD in 2024 to 5.207 billion USD in 2025, driven by science-led innovation, portfolio and geogr

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye